GW Pharma Continues To Move On Takeover Speculation

Takeover speculation around GW Pharmaceuticals PLC- ADR GWPH once again sent shares higher on Thursday.

Back in September, Reuters reported the company had hired Morgan Stanley as an advisor to assist it in handling potential buyers.

At the time, Alan Brochstein, a founding partner at New Cannabis Ventures and the 420 Investor, told Benzinga that, taking into account that the company had not shared full data from two ongoing Phase 3 clinical trials yet, the rumor seemed “a bit premature.”

"I would expect potential acquisition interest to increase after the company files its NDA for Epidiolex in 4-10 months," he added.

The following day, shares tumbled after a company spokesperson said Morgan Stanley had been advising GW Pharmaceuticals for years.

A few weeks later, shares spiked again after the company announced it had achieved its Phase 3 primary endpoint for Epidiolex in Lennox-Gastaut Syndrome, and continued to surge on positive analyst reactions.

On Thursday, the stock gained 3 percent on renewed takeover rumors. A company spokesperson told Benzinga they had “no comment” on the issue.

Posted In: NewsRumorsM&AMovers

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.